New Zealand markets closed

Protagonist Therapeutics, Inc. (PTGX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
25.15+0.49 (+1.99%)
At close: 04:00PM EDT
25.15 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.44B
Enterprise value 1.10B
Trailing P/E N/A
Forward P/E 13.70
PEG ratio (5-yr expected) N/A
Price/sales (ttm)23.33
Price/book (mrq)4.27
Enterprise value/revenue 18.28
Enterprise value/EBITDA -12.14

Trading information

Stock price history

Beta (5Y monthly) 2.05
52-week change 39.12%
S&P500 52-week change 321.08%
52-week high 333.34
52-week low 313.72
50-day moving average 328.35
200-day moving average 321.79

Share statistics

Avg vol (3-month) 3665.94k
Avg vol (10-day) 3457.56k
Shares outstanding 558.27M
Implied shares outstanding 658.27M
Float 840.66M
% held by insiders 11.70%
% held by institutions 1100.42%
Shares short (15 Apr 2024) 43.52M
Short ratio (15 Apr 2024) 45.85
Short % of float (15 Apr 2024) 46.12%
Short % of shares outstanding (15 Apr 2024) 46.05%
Shares short (prior month 15 Mar 2024) 43.42M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -131.59%
Operating margin (ttm)38.41%

Management effectiveness

Return on assets (ttm)-19.32%
Return on equity (ttm)-28.59%

Income statement

Revenue (ttm)60M
Revenue per share (ttm)1.06
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -92.67M
Net income avi to common (ttm)-78.95M
Diluted EPS (ttm)-1.39
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)341.62M
Total cash per share (mrq)5.86
Total debt (mrq)1.14M
Total debt/equity (mrq)0.34%
Current ratio (mrq)16.71
Book value per share (mrq)5.83

Cash flow statement

Operating cash flow (ttm)-70.24M
Levered free cash flow (ttm)-43.31M